C - Chemistry – Metallurgy – 07 – D
Patent
C - Chemistry, Metallurgy
07
D
C07D 263/20 (2006.01) A61K 31/42 (2006.01) A61K 31/505 (2006.01) C07D 263/24 (2006.01) C07D 413/12 (2006.01)
Patent
CA 2132579
Abstract Novel oxazolidinone derivatives of the formula I Image I, in which R1 is a phenyl radical which is unsubstituted or is monosubstituted by CN, H2N-CH2-, A2N-CH2-, H2N-C(=NH)-, H2N-C(=NH)-NH-, H2N-C(=NH)-NH-CH2-, HO-NH-C(=NH)- or HO-NH-C(=NH)-NH-, X is O, S, SO, SO2, -NH- or -NA-, B is Image or Image A is alkyl having from 1 to 6 C atoms, R2 is H, A, Li, Na, K, NH4 or benzyl, R3 is H or (CH2)n-COOR2, E is, in each case independently of each other, CH or N, Q is O, S or NH m is 1, 2 or 3, and n is 0, 1, 2 or 3, and physiologically harmless salts thereof, inhibit the binding of fibrinogen to the corresponding receptor and can be used for treating thrombosis, stroke, cardiac infarction, inflammations, arteriosclerosis, osteoporosis and also tumours.
Bernotat-Danielowski Sabine
Gante Joachim
Juraszyk Horst
Melzer Guido
Raddatz Peter
Fetherstonhaugh & Co.
Merck Patent Gesellschaft Mit Beschraenkter Haftung
LandOfFree
Adhesion receptor antagonists iii does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Adhesion receptor antagonists iii, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Adhesion receptor antagonists iii will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1952964